|
This device is used for treatment not diagnosis.The ventricular assist system is indicated for use as a bridge to cardiac transplantation and destination therapy in patients who are at risk of death from refractory end-stage left ventricular heart failure.The system is designed for in-hospital and out-of-hospital settings.Continuation: vad implanted: (b)(6) 2017, (b)(4) icd implanted: (b)(6) 2019.If information is provided in the future, a supplemental report will be issued.
|
|
A supplemental report is being submitted for device evaluation.Product event summary: the controller ac adapter was returned for evaluation.Various analyses were conducted and reviewed in order to evaluate the performance of the device in relation to the reported event.The controller ac adapter was returned without the clamp assembly attached.Visual inspection also revealed damage to adapter enclosure.Internal inspection did not find any fluid ingress, foreign material, or anomalies with the internal components.The missing clamp assembly and enclosure damage are additional findings unrelated to the reported event and most likely can be attributed to handling of the device.Failure analysis of the returned device revealed that the controller ac adapter passed functional testing.The controller ac adapter was able to adequately provide power to a test controller.As a result, the reported event could not be confirmed or duplicated during testing.A possible cause of the reported event can be attributed to a marginal connection between the controller and controller ac adapter.Investigation of this event is completed and the file will be closed.If new information is received, the file will be re-opened and a supplemental will be submitted.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|